Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial.
about
The Unique Structure of Haemophilus influenzae Protein E Reveals Multiple Binding Sites for Host FactorsImmune responses to HBsAg conjugated to protein D of non-typeable Haemophilus influenzae in miceAnaplasma phagocytophilum surface protein AipA mediates invasion of mammalian host cells.Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study.Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children.Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status.Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses : An Individual Participant Meta-analysis.Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial.Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, contrImmune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial
P2860
Q27675644-F85406CD-C42E-4F1F-9A7E-441C56AAFD5FQ28543439-9E28CC15-40E6-4946-92AE-181E4705AC96Q30371557-293C5004-FF26-477A-BEF2-B8FC294FE1F1Q34033855-FC07FA57-F85E-4919-87CC-4D74763E282DQ34798448-19C485FE-D799-4CF2-AB7C-A4B68471A3F8Q36256464-F6FDAD2F-539D-4A6D-AB0D-94CCA9B9BAB1Q37309298-A3E28882-6D17-4031-88C2-BD8EEADC3720Q37384762-3087172D-16A4-4145-9D57-C12C9090C107Q37606399-E3782E0A-BA09-480B-B636-B36813F58D35Q37613613-2DC61B56-BC4C-44B9-BF88-57076DF64AD9Q37621061-AF719617-68E4-4D3E-844F-9C2ED0A53391Q38246355-B23DC460-7269-4B1B-A5BE-BE313B7C3BAAQ38785828-95B572F4-70AF-48AF-8357-6CC7C34A8949Q38829068-2E7A529C-18B8-4D3A-A8A9-70E12D788CF1Q40285504-8E38248A-7310-4607-B1CC-8EB1AE9D21ADQ56337574-958E5E03-BAEC-4D20-A861-D66FC4312357
P2860
Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Primary vaccination with the 1 ...... a randomized controlled trial.
@ast
Primary vaccination with the 1 ...... a randomized controlled trial.
@en
Primary vaccination with the 1 ...... ae protein D conjugate vaccine
@nl
type
label
Primary vaccination with the 1 ...... a randomized controlled trial.
@ast
Primary vaccination with the 1 ...... a randomized controlled trial.
@en
Primary vaccination with the 1 ...... ae protein D conjugate vaccine
@nl
prefLabel
Primary vaccination with the 1 ...... a randomized controlled trial.
@ast
Primary vaccination with the 1 ...... a randomized controlled trial.
@en
Primary vaccination with the 1 ...... ae protein D conjugate vaccine
@nl
P2093
P2860
P50
P356
P1433
P1476
Primary vaccination with the 1 ...... a randomized controlled trial.
@en
P2093
Abdoulbaki I Diallo
Amadou Barry
Aminata Diallo
Dorota Borys
Gaoussou Santara
Lode Schuerman
Marta Moreira
Nancy François
Olumuyiwa O Odusanya
Omolara A Kehinde
P2860
P2888
P356
10.1186/1471-2458-11-882
P407
P577
2011-11-23T00:00:00Z
P5875
P6179
1009356323